Susumu Tanji

580 total citations
36 papers, 246 citations indexed

About

Susumu Tanji is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Susumu Tanji has authored 36 papers receiving a total of 246 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 10 papers in Surgery and 10 papers in Molecular Biology. Recurrent topics in Susumu Tanji's work include Bladder and Urothelial Cancer Treatments (8 papers), Renal cell carcinoma treatment (7 papers) and Immunotherapy and Immune Responses (6 papers). Susumu Tanji is often cited by papers focused on Bladder and Urothelial Cancer Treatments (8 papers), Renal cell carcinoma treatment (7 papers) and Immunotherapy and Immune Responses (6 papers). Susumu Tanji collaborates with scholars based in Japan. Susumu Tanji's co-authors include Tomoaki Fujioka, Yasushi Suzuki, Wataru Obara, Yasushi Matsushita, Ryuichiro Konda, Karen Kato, Ryuji Nakamura, Ryo Takata, Jun Sugimura and Tachio Aimoto and has published in prestigious journals such as The Journal of Urology, Radiotherapy and Oncology and Radiation Oncology.

In The Last Decade

Susumu Tanji

34 papers receiving 231 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susumu Tanji Japan 10 79 70 66 57 44 36 246
Xubiao Wei China 12 45 0.6× 46 0.7× 61 0.9× 99 1.7× 77 1.8× 27 407
Cecília Farhat Brazil 10 105 1.3× 38 0.5× 64 1.0× 35 0.6× 82 1.9× 26 266
Akira Okada Japan 11 52 0.7× 60 0.9× 137 2.1× 203 3.6× 107 2.4× 16 459
Whitney K. Hendrickson United States 6 143 1.8× 133 1.9× 56 0.8× 24 0.4× 60 1.4× 16 351
J. Ton Van France 7 43 0.5× 13 0.2× 70 1.1× 118 2.1× 52 1.2× 7 289
Toshiya Akao Japan 11 116 1.5× 105 1.5× 159 2.4× 185 3.2× 66 1.5× 29 448
Petra Cetkovská Czechia 10 34 0.4× 47 0.7× 30 0.5× 18 0.3× 29 0.7× 32 345
S. Birkenhake Germany 9 58 0.7× 13 0.2× 83 1.3× 238 4.2× 72 1.6× 19 411
Eric K. Ganguly United States 8 69 0.9× 34 0.5× 57 0.9× 121 2.1× 153 3.5× 23 332

Countries citing papers authored by Susumu Tanji

Since Specialization
Citations

This map shows the geographic impact of Susumu Tanji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susumu Tanji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susumu Tanji more than expected).

Fields of papers citing papers by Susumu Tanji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susumu Tanji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susumu Tanji. The network helps show where Susumu Tanji may publish in the future.

Co-authorship network of co-authors of Susumu Tanji

This figure shows the co-authorship network connecting the top 25 collaborators of Susumu Tanji. A scholar is included among the top collaborators of Susumu Tanji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susumu Tanji. Susumu Tanji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kato, Yoichiro, Shuhei Ishii, Masamichi Suzuki, et al.. (2017). Renal pelvic cancer with spleen invasion arising in horseshoe kidney; a case report. Urology Case Reports. 16. 123–125. 1 indexed citations
2.
Nakamura, Ryuji, et al.. (2013). Three-dimensional summation of rectal doses in brachytherapy combined with external beam radiotherapy for prostate cancer. Radiotherapy and Oncology. 107(2). 159–164. 12 indexed citations
3.
Iwasaki, Kiyotaka, Wataru Obara, Yoichiro Kato, et al.. (2012). Neoadjuvant Gemcitabine Plus Carboplatin for Locally Advanced Bladder Cancer. Japanese Journal of Clinical Oncology. 43(2). 193–199. 12 indexed citations
4.
Nakamura, Ryuji, Susumu Tanji, Ikuko Uwano, et al.. (2012). Narrow safety range of intraoperative rectal irradiation exposure volume for avoiding bleeding after seed implant brachytherapy. Radiation Oncology. 7(1). 15–15. 5 indexed citations
5.
Ishiyama, Hiromichi, Ryuji Nakamura, Takefumi Satoh, et al.. (2010). Differences between intraoperative ultrasound-based dosimetry and postoperative computed tomography-based dosimetry for permanent interstitial prostate brachytherapy. Brachytherapy. 9(3). 219–223. 12 indexed citations
6.
Nakamura, Ryuji, Hiromichi Ishiyama, Susumu Tanji, et al.. (2010). Effects of ellipsoid prostate deformation on dose delivery during permanent interstitial brachytherapy. Brachytherapy. 10(3). 208–213. 2 indexed citations
7.
Ishiyama, Hiromichi, Ryuji Nakamura, Takefumi Satoh, et al.. (2008). Inter-software variability in post-implanted CT analysis for interstitial permanent brachytherapy for prostate cancer: Differences in automatically detected seed location. Radiotherapy and Oncology. 89(2). 214–216. 3 indexed citations
8.
Obara, Wataru, Yasushi Suzuki, Karen Kato, et al.. (2007). Vitamin D receptor gene polymorphisms are associated with increased risk and progression of renal cell carcinoma in a Japanese population. International Journal of Urology. 14(6). 483–487. 41 indexed citations
10.
Fujioka, Tomoaki, et al.. (2000). Telomerase activity in human renal cell carcinoma. International Journal of Urology. 7(1). 16–21. 15 indexed citations
11.
Matsushita, Yasushi, et al.. (1998). [Metastatic renal tumor originating from esophageal carcinoma: a case report].. PubMed. 44(8). 591–4. 8 indexed citations
12.
Fujioka, Tomoaki, et al.. (1998). INHIBITION OF TUMOR GROWTH AND ANGIOGENESIS BY VITAMIN D3 AGENTS IN MURINE RENAL CELL CARCINOMA. The Journal of Urology. 247–251. 4 indexed citations
13.
Matsushita, Yasushi, et al.. (1995). SURGICAL TREATMENT OF RENAL CELL CARCINOMA EXTENDING INTO THE VENA CAVA. International Journal of Urology. 2(4). 224–228. 1 indexed citations
14.
Nomura, Kotaro, et al.. (1994). [Clinical study of renal cell carcinoma invading adjacent organs].. PubMed. 40(5). 373–7. 1 indexed citations
15.
Tanji, Susumu. (1991). EFFECT OF BIOLOGICAL RESPONSE MODIFIERS ON A SPONTANEOUS MURINE RENAL CELL CARCINOMA. The Japanese Journal of Urology. 82(5). 716–725.
16.
Fujioka, Tomoaki, et al.. (1990). Combined effects of intraperitoneal administration of recombinant interleukin-2 and streptococcal preparation OK-432 in murine tumors. International Journal of Immunopharmacology. 12(4). 419–426. 4 indexed citations
17.
Fujioka, Tomoaki, et al.. (1990). Recombinant Interleukin-2-Induced Regression of Pulmonary Metastasis of Renal Cell Carcinoma. Urologia Internationalis. 45(1). 58–62. 1 indexed citations
18.
Tanji, Susumu, et al.. (1990). Studies on Metabolism and Disposition of Sizofiran (SPG), an Anti-tumor Polysaccharide. III. Degradation and Excretion of SPG in Rats. YAKUGAKU ZASSHI. 110(11). 869–875. 9 indexed citations
19.
Fujioka, Tomoaki, et al.. (1990). CLINICAL EFFICACY OF RECOMBINANT INTERLEUKIN-2 FOR RENAL CELL CARCINOMA AND THE EFFECT OF BLOOD TRANSFUSION UPON THE IMMUNE RESPONSE OF THESE PATIENTS. The Japanese Journal of Urology. 81(2). 296–303. 2 indexed citations
20.
Koike, Haruki, et al.. (1989). [Two cases of metastatic renal tumor].. PubMed. 35(3). 475–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026